In an anti-CD4 and anti-CD90 antibody-depleting mouse colitis model, IL-6 was found to contribute to the activation and production of IL-17A, IL-22 and IFN-γ in intestinal ILC3s, a finding confirmed in isolated lamina propria cells from IBD patients [119]. Here, CD4 is linked to inflammatory bowel disease.